Deadline: 28-Apr-2026
The Gates Foundation 2026 invites applications for innovative diagnostic and screening solutions that dramatically reduce costs while enabling scalable deployment in low- and middle-income countries. Funding targets transformative high-risk, high-reward innovations, including AI-driven, software-defined, and platform-based approaches that ensure operational feasibility, cost efficiency, and population-scale impact.
Overview of the Initiative
The Gates Foundation challenge seeks innovative solutions that lower the cost of diagnostic and screening tools for low-resource settings. The program emphasizes technologies that can achieve near-zero incremental cost per test while addressing high-priority disease areas. Applicants are encouraged to propose transformative approaches that integrate advanced sensing, artificial intelligence, software, and platform-based models for scalable, sustainable, and effective deployment.
Focus Areas
Eligible projects should address:
- Cost-disruptive diagnostic devices and $1-class tests
- High-risk, high-reward transformative innovations
- Novel sensing modalities and software-defined diagnostics
- AI-enabled or software-only diagnostic approaches
- Scalable screening with same-visit decision-making
- Cross-sector and multimodal solutions
- Platform-based innovations that improve cost efficiency and sustainability
Key Objectives
- Reduce capital expenses and near-zero incremental costs per test or person screened
- Ensure operational feasibility in high-throughput and low-resource settings
- Address real-world deployment constraints, including affordability and accessibility
- Demonstrate a credible pathway to population-scale adoption and sustainability
- Integrate advanced technologies, including AI, software, and multi-use platforms
Who Can Apply
Eligible applicants include:
- Research institutes and academic institutions
- Nonprofit organizations and international organizations
- For-profit companies and government agencies
Applicants must comply with global access requirements and commit to independent evaluation, ethical practices, and regulatory standards.
Funding and Support
The initiative supports a diverse portfolio of projects ranging from:
- Early-stage, high-risk, high-reward concepts
- Advanced solutions ready for adaptation and scaling
Applicants should provide a clear workplan with milestones, aligned to the maturity of their technology and deployment readiness. Funding supports innovation that can dramatically reduce diagnostic costs while enabling population-scale impact in low- and middle-income countries.
How to Apply
- Identify an innovative diagnostic or screening solution aligned with the program’s focus areas
- Prepare a detailed project proposal, including technical description, workplan, milestones, and cost assumptions
- Ensure compliance with global access, ethical, and regulatory standards
- Submit the proposal through the official Gates Foundation application portal
- Include strategies for scaling, affordability, and population-level deployment
Why This Initiative Matters
The challenge addresses critical barriers to affordable healthcare by funding technologies that enable population-scale diagnosis and screening. By supporting cost-disruptive, scalable solutions, the initiative aims to improve global health outcomes, particularly in low-resource and underserved communities, and accelerate innovation in high-priority disease areas.
Common Mistakes to Avoid
- Submitting proposals without a clear path to cost reduction and population-scale deployment
- Failing to address operational feasibility in low-resource or high-throughput settings
- Ignoring global access, ethical, or regulatory requirements
- Overlooking integration of advanced technologies such as AI, software, or multi-use platforms
- Providing incomplete workplans or unclear milestones aligned with technology maturity
FAQs
1. Who is eligible to apply? Research institutes, nonprofits, for-profits, international organizations, government agencies, and academic institutions.
2. What types of projects are supported? Cost-disruptive diagnostics, AI-driven or software-defined solutions, scalable screening, and platform-based innovations.
3. Is early-stage innovation eligible? Yes, both high-risk early-stage concepts and advanced solutions are supported.
4. Are there global access requirements? Yes, all applicants must comply with global access standards.
5. Should proposals include milestones and workplans? Yes, all applications must outline milestones aligned with technology maturity.
6. What is the primary goal of this initiative? To reduce diagnostic costs while enabling scalable, sustainable deployment in low- and middle-income countries.
7. Are AI or software-only approaches eligible? Yes, AI-enabled and software-only solutions are encouraged, especially if they reduce costs and improve scalability.
Conclusion
The Gates Foundation 2026 challenge provides a strategic opportunity to rethink diagnostic and screening solutions for low-resource settings. By supporting cost-disruptive, scalable, and technologically advanced innovations, the initiative aims to dramatically reduce healthcare costs, improve access to high-priority diagnostics, and enable population-scale impact globally.
For more information, visit Gates Foundation.